Henlius Reported Financial Results for the First Three Quarters of 2023: Total Revenue Exceeded RMB3 9 billion, Profitability Further Improved
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Henlius Reported Financial Results For The First Three Quarters Of 2023: Total Revenue Exceeded RMB3 9 Billion, Profitability Further Improved
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
A new treatment for esophageal squamous cell carcinoma (ESCC) from Shanghai-based Henlius Biotech has been approved by the National Medical Products Administration (NMPA).